Raphael Pharma Relocates HQ to Israel

TL;DR

Raphael Pharma moved its main office to Israel, formerly Easy Energy Inc.

AI Summary

Raphael Pharmaceutical Inc. announced on January 14, 2025, that its principal executive offices are located at 4 Lui Paster, Tel Aviv-Jaffa, Israel, 6803605. This filing also confirms the company's former name was Easy Energy Inc., with a name change date of October 17, 2007. The company is incorporated in Nevada and operates in the medicinal chemicals & botanical products sector.

Why It Matters

The relocation of principal executive offices to Israel may signal a strategic shift for Raphael Pharmaceutical Inc., potentially impacting its operational focus, regulatory landscape, and investor relations.

Risk Assessment

Risk Level: low — This filing primarily concerns administrative changes like office location and former company names, with no immediate financial or operational risks indicated.

Key Players & Entities

• Raphael Pharmaceutical Inc. (company) — Registrant
• Easy Energy Inc. (company) — Former Company Name
• January 14, 2025 (date) — Report Date
• January 8, 2025 (date) — Earliest Event Reported
• October 17, 2007 (date) — Date of Name Change
• Nevada (jurisdiction) — State of Incorporation
• Tel Aviv-Jaffa, Israel (location) — Principal Executive Offices

FAQ

Filing Documents

• ea0227340-8k_raphael.htm (8-K) — 25KB
• 0001213900-25-003401.txt ( ) — 188KB
• raph-20250108.xsd (EX-101.SCH) — 3KB
• raph-20250108_lab.xml (EX-101.LAB) — 33KB
• raph-20250108_pre.xml (EX-101.PRE) — 22KB
• ea0227340-8k_raphael_htm.xml (XML) — 3KB

02 Departure

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensation Arrangements of Certain Officers. On January 8, 2025, the Board of Directors (the "Board") of Raphael Pharmaceuticals Inc. (the "Company") increased the size of its Board by one and appointed Mr. Ajay Kumar Dhadha to serve as a Director of the Company in order to fill the resulting vacancy of the Board. The Board also selected Mr. Dhadha to be Chairman of the Board, replacing Mr. Shlomo Pilo in such role. Mr. Dhadha, age 79, is a diamond dealer and a member of the Israel Diamond Exchange, residing in Israel for the last 45 years. Mr. Dhadha is the founder and owner and Chief Executive Officer of Shanti Gems (1982) Ltd. in Israel, which exports and sells diamonds. There is no arrangement or understanding between Mr. Dhadha and any other person pursuant to which Mr. Dhadha was selected as a Director. There are no transactions, relationships or agreements between Mr. Dhadha and the Company that would require disclosure pursuant to Item 404(a) of Regulation S-K promulgated under the Securities Exchange Act of 1934, as amended. The Board concluded that Mr. Dhadha is qualified to serve as a Director and meets the independence requirement under relevant securities laws. The Company expects to enter into a standard indemnification agreement with Mr. Dhadha. 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. RAPHAEL PHARMACEUTICAL INC. By: /s/ Shlomo Pilo Name: Shlomo Pilo Title: Chief Executive Officer Date: January 14, 2025 2

View Full Filing

View this 8-K filing on SEC EDGAR